In the first episode of its “Amazing Things” podcast series, the national United for Medical Research coalition featured Northwestern Professor and Preora Chairman Vadim Backman, who explains why PWS Nanocytology is a breakthrough method for detecting cancer earlier than ever. (Sept. 13, 2016) Click to view
Company News
Preora Diagnostics Presenting at AdvaMed 2016’s High-profile “Innovation Showcase”
Company also participating in RESI and Cavendish conferences in September 2016.
Click here to read the full story.
AdvaMed 2016 Innovation Showcase
PWS Nanocytology Platform Named one of “Six New Medical Technologies Worth Watching”
The Wall Street Journal (June 26, 2016) highlighted our screening tests as an emerging technology that “could have a big impact on medicine in the coming years.”
Click here to read the full story.
Wall Street Journal Article
iBIO PROPEL Highlights Preora Diagnostics
In its semi-annual newsletter to investors, the Illinois Biotechnology Industry Organization profiled Preora as a company to watch (excerpt from Feb. 2016 issue)
Click here to read the full story.
iBIO Newsletter
Preora Diagnostics Chairman Vadim Backman Addresses Milken Institute Global Conference 2016
Dr. Backman joins Nobel Laureate and other medical experts for prestigious panel discussion. Click to view.
Start-Up Magazine Highlights Preora Diagnostics
The highly respected and industry-leading Start-up magazine profiled Preora Diagnostics in its September 2015 issue.
Click here to read the full story.
Start-up Profile
Preora Diagnostics to Present at AdvaMed 2015: The MedTech Conference
Preora President and CEO John W. Hart will participate in the prestigious “Innovation Showcase” at AdvaMed 2015 on October 7.
Click here to read the full story.
Preora to Present at AdvaMed_09.10.15
Preora Diagnostics to Commercialize Cancer Pre-screening Tests
NanoCytomics LLC today announced the formation of Preora Diagnostics Inc., a privately held medical technology company that will bring low-cost cancer pre-screening tests to primary care physicians in the U.S. and other select markets.
Click here to read the full story.
Preora Launch Release
NanoCytomics Earns Spot in Chicago’s MATTER Community
MATTER, Chicago’s new entrepreneurship and innovation hub for next-generation health IT, medical device, diagnostics and biopharma companies, has named NanoCytomics as an early member of its expanding community.
Click here to read the full story.
MATTER News Release
NanoCytomics President John W. Hart Profiled in White City News
On the day of the July 17 announcement of John Hart joining NanoCytomics as president, and again as the lead story in its July 21 weekly news roundup, White City News profiled John W. Hart in an exclusive interview with the influential Chicago life sciences blog.
Click here to read the full story.
White City News Article